{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/EYPT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-08T09:59:07.375Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6322,"canonical_name":"EyePoint, Inc.","cik":"0001314102","uei":null,"lei":null,"duns":null,"ticker":"EYPT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":22},"count":22,"timeline":[{"ts":"2026-07-22","kind":"sec.form144","reporter":"Lurker Nancy","title":"Officer","shares":1235,"usd_value":15820,"security_title":"Common","approx_sale_date":"2026-07-22","accession_number":"0001959173-26-005318","importance":40.003164},{"ts":"2026-07-22","kind":"sec.form144","reporter":"Lurker Nancy","title":"Director","shares":1235,"usd_value":15820,"security_title":"Common","approx_sale_date":"2026-07-22","accession_number":"0001959173-26-005330","importance":40.003164},{"ts":"2026-07-22","kind":"sec.filing","form_type":"144/A","title":"144/A — EyePoint, Inc. — 2026-07-22","url_slug":"/sec/cik-0001314102/144-a/0001959173-26-005318","accession_number":"0001959173-26-005318","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"144/A","title":"144/A — EyePoint, Inc. — 2026-07-22","url_slug":"/sec/cik-0001314102/144-a/0001959173-26-005330","accession_number":"0001959173-26-005330","importance":30},{"ts":"2026-07-21","kind":"sec.form144","reporter":"Lurker Nancy","title":"Officer","shares":421235,"usd_value":5497117,"security_title":"Common","approx_sale_date":"2026-07-21","accession_number":"0001959173-26-005309","importance":41.09942335},{"ts":"2026-07-21","kind":"sec.filing","form_type":"144","title":"144 — EyePoint, Inc. — 2026-07-21","url_slug":"/sec/cik-0001314102/144/0001959173-26-005309","accession_number":"0001959173-26-005309","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"8-K","title":"8-K — EyePoint, Inc. — 2026-07-17","url_slug":"/sec/cik-0001314102/8-k/0001193125-26-307792","accession_number":"0001193125-26-307792","importance":35},{"ts":"2026-07-14","kind":"sec.filing","form_type":"4","title":"4 — EyePoint, Inc. — 2026-07-14","url_slug":"/sec/cik-0001314102/4/0001630864-26-000010","accession_number":"0001630864-26-000010","importance":30},{"ts":"2026-07-10","kind":"sec.insider.f","reporter":"Duker Jay S.","title":"President and CEO","shares":8059,"price_per_share":14.72,"usd_value":118628,"security_title":"Common Stock","importance":15.11862848},{"ts":"2026-07-10","kind":"sec.insider.m","reporter":"Duker Jay S.","title":"President and CEO","shares":16667,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — EyePoint, Inc. — 2026-07-02","url_slug":"/sec/cik-0001314102/4/0002013623-26-000012","accession_number":"0002013623-26-000012","importance":30},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Ribeiro Ramiro","title":"Chief Medical Officer","shares":2438,"price_per_share":15.0172,"usd_value":36612,"security_title":"Common Stock","importance":35.0366119336},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Ribeiro Ramiro","title":"Chief Medical Officer","shares":2437,"price_per_share":15,"usd_value":36555,"security_title":"Common Stock","importance":35.036555},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Ribeiro Ramiro","title":"Chief Medical Officer","shares":2438,"price_per_share":8.26,"usd_value":20138,"security_title":"Common Stock","importance":15.02013788},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Ribeiro Ramiro","title":"Chief Medical Officer","shares":2437,"price_per_share":8.26,"usd_value":20130,"security_title":"Common Stock","importance":15.02012962},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — EyePoint, Inc. — 2026-06-22","url_slug":"/sec/cik-0001314102/8-k/0001193125-26-276688","accession_number":"0001193125-26-276688","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — EyePoint, Inc. — 2026-06-03","url_slug":"/sec/cik-0001314102/schedule-13g/0001831942-26-000028","accession_number":"0001831942-26-000028","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — EyePoint, Inc. — 2026-05-15","url_slug":"/sec/cik-0001314102/schedule-13g-a/0001104659-26-062616","accession_number":"0001104659-26-062616","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — EyePoint, Inc. — 2026-05-14","url_slug":"/sec/cik-0001314102/8-k/0001193125-26-222750","accession_number":"0001193125-26-222750","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — EyePoint, Inc. — 2026-05-13","url_slug":"/sec/cik-0001314102/schedule-13g-a/0000919574-26-002911","accession_number":"0000919574-26-002911","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — EyePoint, Inc. — 2026-04-27","url_slug":"/sec/cik-0001314102/def-14a/0001193125-26-182035","accession_number":"0001193125-26-182035","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — EyePoint, Inc. — 2026-04-27","url_slug":"/sec/cik-0001314102/defa14a/0001193125-26-182077","accession_number":"0001193125-26-182077","importance":30}]}